Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy.
Enforcement
Harm reduction
Lessons learned
Opioid crisis
Prevention
Treatment
Journal
Substance abuse treatment, prevention, and policy
ISSN: 1747-597X
Titre abrégé: Subst Abuse Treat Prev Policy
Pays: England
ID NLM: 101258060
Informations de publication
Date de publication:
19 08 2019
19 08 2019
Historique:
received:
17
05
2019
accepted:
07
08
2019
entrez:
21
8
2019
pubmed:
21
8
2019
medline:
6
5
2020
Statut:
epublish
Résumé
Canada is facing an urgent challenge to reduce the harms associated with opioids: from January 2016 to December of 2018, more than 11,500 individuals lost their lives due to opioid related harms. This review examines responses to the opioid crisis thus far, the lessons learned from these initiatives and the knowledge gaps that still need to be addressed across the four pillar model adopted by the CDSS. A search of peer-reviewed literature was conducted in PubMed and PsycNet, and grey literature was retrieved from reputable substance use and health organizations to determine responses to the opioid crisis and related outcomes between 2013 and 2019. Findings related to actions, outcomes and unintended consequences across the categories of prevention, treatment, harm reduction, enforcement and the evidence base were included and synthesized into a narrative review on lessons learned. The opioid crisis is a result of multiple, complex interrelated factors. Many physicians may not feel competent to appropriately treat pain and/or addiction. Pushes for opioid deprescribing have resulted in some individuals using illicit opioids as treatment. A range of effective and accessible pharmacological and psychological treatments are still required. When regulations are barriers, unsanctioned actions, such as overdose prevention sites, may be enacted by individuals to respond to urgent public health needs. A nimble response with evolving enforcement perspectives can aid individuals experiencing harms from opioid use. There is no one size fits all response to this crisis, and consideration should be given to the unique needs of different communities and populations, as well as the broader impact of harms on families, communities, and society. A situation so multifaceted requires both immediate and long-term strategies implemented concurrently in order to address the differing and on-going needs of Canadians experiencing opioid harms. The expertise of individuals and families affected by the opioid crisis must be included in consultations and decisions related to different strategies, to ensure responses are not stigmatizing, that they will be effective and acceptable and that unintended consequences are quickly recognized and mitigated.
Sections du résumé
BACKGROUND
Canada is facing an urgent challenge to reduce the harms associated with opioids: from January 2016 to December of 2018, more than 11,500 individuals lost their lives due to opioid related harms. This review examines responses to the opioid crisis thus far, the lessons learned from these initiatives and the knowledge gaps that still need to be addressed across the four pillar model adopted by the CDSS.
METHODS
A search of peer-reviewed literature was conducted in PubMed and PsycNet, and grey literature was retrieved from reputable substance use and health organizations to determine responses to the opioid crisis and related outcomes between 2013 and 2019. Findings related to actions, outcomes and unintended consequences across the categories of prevention, treatment, harm reduction, enforcement and the evidence base were included and synthesized into a narrative review on lessons learned.
RESULTS
The opioid crisis is a result of multiple, complex interrelated factors. Many physicians may not feel competent to appropriately treat pain and/or addiction. Pushes for opioid deprescribing have resulted in some individuals using illicit opioids as treatment. A range of effective and accessible pharmacological and psychological treatments are still required. When regulations are barriers, unsanctioned actions, such as overdose prevention sites, may be enacted by individuals to respond to urgent public health needs. A nimble response with evolving enforcement perspectives can aid individuals experiencing harms from opioid use.
CONCLUSIONS
There is no one size fits all response to this crisis, and consideration should be given to the unique needs of different communities and populations, as well as the broader impact of harms on families, communities, and society. A situation so multifaceted requires both immediate and long-term strategies implemented concurrently in order to address the differing and on-going needs of Canadians experiencing opioid harms. The expertise of individuals and families affected by the opioid crisis must be included in consultations and decisions related to different strategies, to ensure responses are not stigmatizing, that they will be effective and acceptable and that unintended consequences are quickly recognized and mitigated.
Identifiants
pubmed: 31426814
doi: 10.1186/s13011-019-0220-7
pii: 10.1186/s13011-019-0220-7
pmc: PMC6700784
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
32Références
Drug Alcohol Depend. 2017 Apr 01;173 Suppl 1:S65-S72
pubmed: 28363322
Addiction. 2019 Sep;114(9):1602-1613
pubmed: 31166621
Subst Abuse Treat Prev Policy. 2018 May 25;13(1):20
pubmed: 29801458
Med Care. 1981 Feb;19(2):127-40
pubmed: 7206846
Pain Res Manag. 2009 Nov-Dec;14(6):439-44
pubmed: 20011714
CMAJ. 2016 Dec 6;188(17-18):1240-1244
pubmed: 27821465
Ann Intern Med. 2018 Jun 5;168(11):783-790
pubmed: 29801093
Ann Surg. 2018 Mar;267(3):468-472
pubmed: 28267689
JAMA. 2018 Dec 18;320(23):2427-2428
pubmed: 30561463
J Chiropr Med. 2006 Autumn;5(3):101-17
pubmed: 19674681
Pain Physician. 2012 Jul;15(3 Suppl):ES169-75
pubmed: 22786455
Expert Opin Pharmacother. 2017 Mar;18(4):329-333
pubmed: 28132576
J Behav Health Serv Res. 2013 Jan;40(1):111-20
pubmed: 23093443
Clin Ther. 2007;29 Suppl:2589-602
pubmed: 18164924
Int J Drug Policy. 2018 Jul;57:104-110
pubmed: 29715589
Harm Reduct J. 2018 Jul 5;15(1):35
pubmed: 29976203
Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S199-S202
pubmed: 28334467
Health Promot Chronic Dis Prev Can. 2018 Jun;38(6):224-233
pubmed: 29911818
Pain Physician. 2009 May-Jun;12(3):507-15
pubmed: 19461820
JAMA. 2018 Dec 18;320(23):2448-2460
pubmed: 30561481
Health Promot Chronic Dis Prev Can. 2018 Sep;38(9):312-316
pubmed: 30226724
JAMA. 2015 Apr 28;313(16):1636-44
pubmed: 25919527
JAMA Netw Open. 2019 Jan 4;2(1):e186007
pubmed: 30657529
Drug Alcohol Depend. 2018 Aug 1;189:90-95
pubmed: 29894910
Int J Drug Policy. 2018 May;55:77-79
pubmed: 29524736
Can J Public Health. 2017 Sep 14;108(3):e325-e327
pubmed: 28910257
Can J Public Health. 2018 Apr;109(2):231-232
pubmed: 29981029
CMAJ. 2018 Jan 22;190(3):E90-E91
pubmed: 29358208
BMC Fam Pract. 2017 Nov 25;18(1):94
pubmed: 29178843
Subst Abuse Treat Prev Policy. 2017 Nov 2;12(1):45
pubmed: 29096653
Int J Drug Policy. 2018 Nov;61:52-58
pubmed: 30344005
Harm Reduct J. 2017 May 18;14(1):28
pubmed: 28521829
Can Fam Physician. 2017 Dec;63(12):906-908
pubmed: 29237624
Am J Public Health. 2014 Aug;104(8):e32-42
pubmed: 24922138
Drug Alcohol Depend. 2017 Apr 1;173 Suppl 1:S1-S3
pubmed: 28363314
Drug Alcohol Depend. 2018 Oct 1;191:86-90
pubmed: 30096638
J Addict Behav Ther Rehabil. 2013 May 27;2(2):
pubmed: 25401117
CMAJ. 2018 Mar 5;190(9):E247-E257
pubmed: 29507156
Can J Anaesth. 2016 Jan;63(1):61-8
pubmed: 26507535
Public Health Rep. 2002;117 Suppl 1:S135-45
pubmed: 12435837
BMJ. 2018 Aug 29;362:k3207
pubmed: 30158106
CMAJ. 2017 Jan 9;189(1):E46-E47
pubmed: 27895142